Mettler-Toledo International Inc Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
5-Yr Fwd EPS Growth
10.4%projected annual EPS growth
Analyst Coverage
11analysts covering
FY Revenue (est.)
$4.2Bnext fiscal year
FY EPS (est.)
$47.34next fiscal year
Monitoring Framework
Key Performance Indicators
Local Currency Sales Growth Quarterly3.0%
Adjusted Diluted EPS Growth Quarterly9.0%Target: 8 to 10%
Free Cash Flow Annually
Watch Items
- Recovery in Pharmaceutical and Biotech Lab SpendingTrigger: Stabilization of lab segment sales decline toward positive growthAction: Re-evaluate segment revenue forecasts and adjust overall growth expectations
- Product Inspection Segment MomentumTrigger: Sustained double-digit local currency sales growthAction: Assess capacity allocation and marketing spend to capitalize on automation demand
Research as of 2 Sep 2026